Catherine Moukheibir, Director at MoonLake Immunotherapeutics (MLTX), sold 23,500 shares at $48.79 ($1.1M) on 2025-07-03, disclosed to the SEC on 2025-07-07.
Open-market sale of $1.1M MLTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.